COMPANY NAME
SUDA board members Joseph Ohayon , Michael Stewart and Stephen Carter
“ The challenges of formulating a tablet into a spray are solubility , stability and permeation . With solubility , we have to get the dose drug dissolved in a certain amount of liquid .”
“ With stability , there are a lot of drugs that are stable in dry powder , but will degrade immediately in a solution , so we have techniques and know-how to overcome stability issues .”
“ With permeation , the question is how you formulate it so the drug is rapidly absorbed . We have knowhow and access to proprietary permeation enhancers . That ’ s what differentiates us .”
INVESTOR MAGNET Through its in-house pipeline , SUDA specialises in formulating products and developing them through clinical studies to a stage that
50 March 2016